G. Garcia‐Tsao

Hepatology · 2000–2021

A researcher in the Science corpus: 17 papers; trusts 1 researcher and is trusted by 9 researchers here, as inferred from the citation graph.

Subfields

Whom G. Garcia‐Tsao trusts overall

Their strongest outbound trust, strongest first, inferred from their citations.

  1. B. Runyon

Who trusts G. Garcia‐Tsao overall

  1. P. Angeli
  2. Z. Goodman
  3. M. Bernardi
  4. P. Ginés
  5. Aasld Idsa Hcv Guidance Panel
  6. J. Bosch
  7. C. Villanueva
  8. J. Llovet

Papers from G. Garcia‐Tsao's perspective

Ordered by how strongly the researchers G. Garcia‐Tsao trusts endorse each paper. Same corpus, a different order for every researcher.

  1. The management of ascites in cirrhosis: Report on the consensus conference of the international Ascites club (Hepatology)
  2. Diagnosis and management of acute kidney injury in patients with cirrhosis: revised consensus recommendations of the International Club of Ascites (Gut)
  3. Prevalence and risk factors of infections by multiresistant bacteria in cirrhosis: A prospective study (Hepatology)
  4. Acute-on-chronic liver failure is a distinct syndrome that develops in patients with acute decompensation of cirrhosis. (Gastroenterology)
  5. TLR4 enhances TGF-beta signaling and hepatic fibrosis. (Nature Medicine)
  6. Revising consensus in portal hypertension: report of the Baveno V consensus workshop on methodology of diagnosis and therapy in portal hypertension. (Journal of Hepatology)
  7. Recommendations for the diagnosis and management of corticosteroid insufficiency in critically ill adult patients: Consensus statements from an international task force by the American College of… (Critical Care Medicine)
  8. Multidrug-resistant, extensively drug-resistant and pandrug-resistant bacteria: an international expert proposal for interim standard definitions for acquired resistance. (Clinical Microbiology and Infection)
  9. Hepatic venous pressure gradient predicts clinical decompensation in patients with compensated cirrhosis. (Gastroenterology)
  10. Rifaximin in the treatment of hepatic encephalopathy (Hepatic Medicine : Evidence and Research)

Their papers